Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Kandzari

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007
Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapyP A Gurbel, D E Kandzari
Seminars in Cell Biology|June 1, 1994
Growth factor receptors, phospholipases, phospholipid kinases and actin reorganizationS J Gips, D E Kandzari, P J Goldschmidt-Clermont
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2000
Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitisD E Kandzari, J J Warner, M P O'Laughlin, et al.
The Journal of Cardiovascular Surgery|April 24, 2008
Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trialM Carrier, R Emery, D E Kandzari, et al.
Circulation Research|February 1, 1996
EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinaseA W Heldman, D E Kandzari, R W Tucker, et al.
American Heart Journal|October 31, 2001
Advanced coronary artery disease: Appropriate end points for trials of novel therapiesD E Kandzari, L C Lam, E L Eisenstein, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007
Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapyP A Gurbel, D E Kandzari
Seminars in Cell Biology|June 1, 1994
Growth factor receptors, phospholipases, phospholipid kinases and actin reorganizationS J Gips, D E Kandzari, P J Goldschmidt-Clermont
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2000
Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitisD E Kandzari, J J Warner, M P O'Laughlin, et al.
The Journal of Cardiovascular Surgery|April 24, 2008
Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trialM Carrier, R Emery, D E Kandzari, et al.
Circulation Research|February 1, 1996
EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinaseA W Heldman, D E Kandzari, R W Tucker, et al.
American Heart Journal|October 31, 2001
Advanced coronary artery disease: Appropriate end points for trials of novel therapiesD E Kandzari, L C Lam, E L Eisenstein, et al.
Pageof 1